The subgroup analysis by age revealed a notable trend, with the greatest protective effect of denosumab observed in patients aged 80 years and older.
← all excerpts
Incidence of Total Knee Arthroplasty in Older Females with Knee Osteoarthritis and Osteoporosis Treated with Denosumab Compared with Those Treated Using Bisphosphonates: A Population-Based Cohort Study.
1
—
—